A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : CG / cardiac glycoside

[Related PubMed/MEDLINE]
Total Number of Papers: 29
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   CG  (>> Co-occurring Abbreviation)
Long Form:   cardiac glycoside
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Cardiac Glycoside Compound Isolated from Helleborus thibetanus Franch Displays Potent Toxicity against HeLa Cervical Carcinoma Cells through ROS-Independent Autophagy. NAC
2019 Sodium chloride (NaCl) potentiates digoxin-induced anti-tumor activity in small cell lung cancer. SCLC
2018 A cardiac glycoside HTF-1 isolated from Helleborus thibetanus Franch displays potent invitro anti-cancer activity via caspase-9, MAPK and PI3K-Akt-mTOR pathways. ---
2018 Preconditioning and Postconditioning by Cardiac Glycosides in the Mouse Heart. DigPC, OPC
2017 Hydroalcoholic extract from Nerium oleander L. (Apocynaceae) elicits arrhythmogenic activity. OLE
2016 Ischemia/reperfusion-induced alterations of enzymatic and signaling functions of the rat cardiac Na+/K+-ATPase: protection by ouabain preconditioning. I/R
2016 Transcriptome and Metabolite analysis reveal candidate genes of the cardiac glycoside biosynthetic pathway from Calotropis procera. ---
2014 Monosaccharide digitoxin derivative sensitize human non-small cell lung cancer cells to anoikis through Mcl-1 proteasomal degradation. GSK
2014 Real-time analysis of the effects of toxic, therapeutic and sub-therapeutic concentrations of digitoxin on lung cancer cells. NSCLC
10  2013 Nerium oleander derived cardiac glycoside oleandrin is a novel inhibitor of HIV infectivity. ---
11  2012 Human cytomegalovirus inhibition by cardiac glycosides: evidence for involvement of the HERG gene. HCMV, mERG
12  2009 Digoxin may provide protection against vasospasm in subarachnoid haemorrhage. SAH
13  2008 Inhibition of the sodium/potassium ATPase impairs N-glycan expression and function. L-PHA
14  2006 Effects of Urginea sanguinea, a traditional asthma remedy, on embryo neuronal development. ---
15  2005 Urginea sanguinea: medicinal wonder or death in disguise? ---
16  2001 Region specific regulation of sodium pump isoform and Na,Ca-exchanger expression in the failing human heart--right atrium vs left ventricle. LV, NCX, RA
17  1999 Identification and quantification of cardiac glycosides in blood and urine samples by HPLC/MS/MS. CID, ESI, SIM, SRM
18  1999 [The action of a number of cardiac glycosides on an isolated system of myocardial contractile proteins in heart failure due to toxic-allergic myocarditis. The molecular mechanism]. AME, CI, MF, SK, TAM10dd
19  1996 Mediation of cardiac glycoside insensitivity in the monarch butterfly (Danaus plexippus): Role of an amino acid substitution in the ouabain binding site of Na(+),K (+)-ATPase. HEK
20  1995 [Endogenous digitalis-like substance. I. Basic characteristics]. EDLS
21  1989 Development of a specific assay for cardiac glycoside-like compounds based on cross-resistance of human cell mutants. ---
22  1987 Structure-activity relationships of progesterone derivatives that bind to the digitalis receptor: modifications in A and B rings. RBA
23  1986 [Pharmacologic study of a semisynthetic digitalis derivative lacking the hydroxyl group on position 14 of the steroid nucleus]. LD, OAM, SAT
24  1985 Progesterone derivatives that bind to the digitalis receptor: effects on Na+,K+-ATPase and isolated tissues. CMA, PROG, RRA
25  1984 Progesterone derivatives that bind to the digitalis receptor: effects on 86Rb uptake and contractility in the isolated guinea pig heart. CMA
26  1983 [Radionuclide study of the influence of beta-adrenoblockaders on the cardiotonic effect of cardiac glycosides]. BAB
27  1980 [Smooth muscle and cardiac glycosides (author's transl)]. ---
28  1976 On the sarcolemmal site of action of cardiac glycosides. ECS, SR
29  1975 Cardiac effects of ethacrynic acid, a Na+, K+-ATPase inhibitor. AP, CP, DP